Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients

Impact of polypharmacy on inducing blood dyscrasias in clozapine treated patients

Introduction Clozapine is commonly associated with hematological side effects. However, little research is available on the impact of adding other psychotropic medication on inducing blood dyscrasias. Objectives The aim of the study was to explore the impact of associating psychotropic medication...

Full description

Bibliographic Details
Main Authors:	M. Shiri, A. Ouertani, U. Ouali, R. Jomli
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-06-01
Series:	European Psychiatry
Subjects:	clozapine psychotropic medication Polypharmacy blood dyscrasias
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933822018557/type/journal_article

Similar Items

Incidence of clozapine-induced hematological side effects in a Tunisian population
by: M. Shiri, et al.
Published: (2022-06-01)

Sex-dependent effects of long-term clozapine or haloperidol medication on red blood cells and liver iron metabolism in Sprague Dawley rats as a model of metabolic syndrome
by: Marie-Luise Bouvier, et al.
Published: (2022-01-01)

Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01)

Characterising the evolution of antipsychotic polypharmacy and clozapine prescribing patterns in schizophrenia patients during psychiatric hospitalisations
by: J. Lagreula, et al.
Published: (2022-06-01)

Oral manifestations of white blood cell dyscrasias with emphasis on their management
by: Amritha James, et al.
Published: (2021-01-01)

Successful clozapine rechallenge after neutropenia using lithium carbonate : a case report
by: D. Khattech, et al.
Published: (2022-06-01)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
by: Julie M. Zito, et al.
Published: (2021-06-01)

Polypharmacy in psychiatric practice in the Canary Islands
by: Sanz Emilio J, et al.
Published: (2004-07-01)

Clinical and pharmacological factors influencing serum clozapine and norclozapine levels
by: Anna Mach, et al.
Published: (2024-03-01)

Psychotropic drug prescription patterns and their predictors among older adult patients with schizophrenia in a tertiary-referral psychiatric hospital
by: Mu- Chun Lin, et al.
Published: (2021-01-01)

Polypharmacy and Mental Health Issues in the Senior Hemodialysis Patient
by: Maša Knehtl, et al.
Published: (2022-05-01)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
by: I. Kammoun, et al.
Published: (2022-06-01)

A case of plasma cell dyscrasia presenting as nonscarring alopecia
by: Benjamin Nia, MD, et al.
Published: (2021-09-01)

Differential diagnosis of plasma cell dyscrasias in rheumatological practice
by: V I Vasilyev, et al.
Published: (2010-12-01)

Prevalence of Oral and Craniofacial Manifestations of Hematological Dyscrasias at Shiraz Nemazee Hospital
by: Janan Ghapanchi, et al.
Published: (2014-07-01)

Prevalence and prescribers’ knowledge of psychotropic polypharmacy in the Bono, Bono East, and Ahafo Regions, Ghana
by: James Dumba, et al.
Published: (2024-01-01)

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
by: Gilles Loggia, et al.
Published: (2020-01-01)

Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study
by: Celica Glenn Cosme, et al.
Published: (2024-01-01)

A Retrospective Chart Review of Factors Impacting Psychotropic Prescribing Patterns and Polypharmacy Rates in Youth with Autism Spectrum Disorder during the COVID-19 Pandemic
by: Evan Taniguchi, et al.
Published: (2022-08-01)

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland
by: Sophie Lonchampt, et al.
Published: (2021-06-01)

Clozapine-induced myocarditis: a case report and literature review
by: I. Angélico Ferreira, et al.
Published: (2022-06-01)

Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study
by: Jie Hu, et al.
Published: (2022-11-01)

Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study
by: Amanda J. Wheeler, et al.
Published: (2020-06-01)

Clozapine-induced hypertension
by: Vrushti Bharat Patil, et al.
Published: (2022-01-01)

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
by: Eugenio Morelli, et al.
Published: (2020-01-01)

Two cases of clozapine induced thrombocytosis
by: N. Liyanage, et al.
Published: (2016-06-01)

Clozapine use at a specialised psychiatric hospital in Johannesburg
by: Katherine L. Ord, et al.
Published: (2023-04-01)

A growing heart: a literary review on clozapine-induced Myocarditis
by: F. Ramalheira, et al.
Published: (2022-06-01)

Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)

Clozapine-induced acute hypertriglyceridemia
by: Mitesh Kumar, et al.
Published: (2017-01-01)

The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma
by: Yanjie Xu, et al.
Published: (2023-02-01)

Severe Clozapine Poisoning Treated by Extracorporeal Blood Purification Therapy
by: Andreas Hartjes, et al.
Published: (2023-07-01)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
by: Ebenezer Oloyede, et al.
Published: (2023-06-01)

Catatonia induced by abrupt discontinuation of clozapine - case report
by: C. Oliveira, et al.
Published: (2021-04-01)

Ethanol and Medical Psychotropics Co-Consumption in European Countries: Results from a Three-Year Retrospective Study of Forensic Samples in Spain
by: Maira Almeida-González, et al.
Published: (2022-12-01)

Evaluation of psychotropic medications use among elderly with psychiatric disorders in Saudi Arabia
by: Abdulkarim M. Meraya, et al.
Published: (2021-06-01)

Death due to intestinal obstruction in a patient treated with clozapine
by: NL Abeyasinghe, et al.
Published: (2010-12-01)

Death due to intestinal obstruction in a patient treated with clozapine
by: NL Abeyasinghe, et al.
Published: (2010-12-01)

Utilization of Psychotropic Medications and Polypharmacy Among Adults in Jazan Region, Saudi Arabia
by: Abdulkarim M. Meraya, et al.
Published: (2020-09-01)

Risperidone-induced reversible neutropenia
by: Kattalai Kailasam V, et al.
Published: (2017-07-01)